A Keio University-originated medtech startup developing BCI-based neurorehabilitation devices for stroke recovery.

What is the goal of this research?

To evaluate the efficacy and safety of BCI-based rehabilitation for severe upper limb paralysis after stroke.

Where will the research be conducted?

Hokkaido University is the supporting institution, with Prof. Mukano leading the physician-led clinical trial.

What is BCI technology?

Brain-Computer Interface reads brain signals to control external devices, used here to support motor rehabilitation.

Who are the target patients?

Patients with severe upper limb paralysis after stroke, who have limited recovery with conventional therapy.

LIFESCAPES Selected for AMED's FY2026 'Bridging Research Program'

Key facts

LIFESCAPES Selected for AMED's FY2026 'Bridging Research Program'
LIFESCAPES Inc. has been selected for the FY2026 'Bridging Research Program' by the Japan Agency for Medical Research and Development (AMED). In collaboration with Hokkaido University and Professor Masahiko Mukano, the company will conduct a physician-led clinical trial evaluating BCI-based neurorehabilitation for severe post-stroke upper limb dysfunction.
Source: PR TIMES
Date: Thu Jun 18 2026 19:30:36 GMT+0900 (Japan Standard Time)

Direct answer

LIFESCAPES Inc. has been selected for the FY2026 'Bridging Research Program' by the Japan Agency for Medical Research and Development (AMED). In collaboration with Hokkaido University and Professor Masahiko Mukano, the company will conduct a physician-led clinical trial evaluating BCI-based neurorehabilitation for severe post-stroke upper limb dysfunction.

Citation: LIFESCAPES Selected for AMED's FY2026 'Bridging Research Program' (Thu Jun 18 2026 19:30:36 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Thu Jun 18 2026 19:30:36 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

LIFESCAPES Inc. has been selected for the FY2026 'Bridging Research Program' by the Japan Agency for Medical Research and Development (AMED). In collaboration with Hokkaido University and Professor Masahiko Mukano, the company will conduct a physician-led clinical trial evaluating BCI-based neurorehabilitation for severe post-stroke upper limb dysfunction.

AI Analysis

Frequently Asked Questions

Q: What is LIFESCAPES?: A: A Keio University-originated medtech startup developing BCI-based neurorehabilitation devices for stroke recovery.
Q: What is the goal of this research?: A: To evaluate the efficacy and safety of BCI-based rehabilitation for severe upper limb paralysis after stroke.
Q: Where will the research be conducted?: A: Hokkaido University is the supporting institution, with Prof. Mukano leading the physician-led clinical trial.
Q: What is BCI technology?: A: Brain-Computer Interface reads brain signals to control external devices, used here to support motor rehabilitation.
Q: Who are the target patients?: A: Patients with severe upper limb paralysis after stroke, who have limited recovery with conventional therapy.